We are live on ! Find out more
MDCXW

Medicus Pharma Warrant

7 hedge funds and large institutions have $308K invested in Medicus Pharma Warrant in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

65% more capital invested

Capital invested by funds: $187K → $308K (+$121K)

17% more funds holding

Funds holding: 67 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$158K
CS
2
Clear Street
New York
$46K +$25.4K +24,453 +59%
WAM
3
Warberg Asset Management
Illinois
$45.5K +$38.9K +37,549 +137%
AC
4
Armistice Capital
New York
$42.4K +$62.8K +60,600 New
PAG
5
Private Advisor Group
New Jersey
$10.5K +$15.6K +15,000 New
CCM
6
Connective Capital Management
California
$4.2K
UBS Group
7
UBS Group
Switzerland
$1.61K +$310 +299 +15%
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
-$26.9K -41,300 Closed

MDCXW Hedge Fund Activity: Q1 2025 in Review

7 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q1 2025, worth a combined $308K — up 65% from $187K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDCXW positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $62.8K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $26.9K sold.

  • 7 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q1 2025, up from 6 in Q4 2024.
  • Funds reported $308K of Medicus Pharma Warrant stock for Q1 2025, up 65% quarter-over-quarter.
  • 2 funds opened new Medicus Pharma Warrant positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest Medicus Pharma Warrant buyer in Q1 2025 was Armistice Capital, an estimated $62.8K added.
  • The largest Medicus Pharma Warrant seller in Q1 2025 was Hudson Bay Capital Management, an estimated $26.9K sold.

Based on aggregated 13F filings for Q1 2025.